cell survival in response to doxorubicin ( dx ) and cis-diammine-dichloroplatinum ( cis-pt ) administration , either alone or combined with hyperthermic treatment , was analyzed in human osteosarcoma ( u-2-os ) , murine melanoma ( b16v ) and murine leukemia ( p388 ) cell lines and in dx-resistant sublines derived from b16v and p388 .
C0008838
cis-diammine-dichloroplatinum
C0029463
osteosarcoma